Insider filing · DXCM
Mark G Foletta
Director
profile →
DexCom, Inc.
DXCM · Healthcare · 49 filings in 24 months
ticker →
Mark G Foletta sold $282K of DexCom (DXCM)
Executed Jun 15, disclosed Jun 17, 2 days later.
Value, as filed
$282K
3,801 sh × $74.10
Executed
Jun 15
the trade date, as filed
Disclosed
Jun 17
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MFMark G Foletta (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in DexCom, Inc. (DXCM). The largest single filing was $331K of DXCM (4,000 sh across 2 lots, as filed), executed Jul 31.
The name
DXCMHealthcare · DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) sy…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mark G Foletta in DXCM
DXCMSALE
DexCom, Inc.
$331K4,000 sh across 2 lots
Exec Jul 31
Filed Aug 4 · 4:38 PM ET DXCMSALE DexCom, Inc. $207K
2,555 sh × $81.02
Exec Aug 15 2025
Filed Aug 18 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. $234K
2,742 sh × $85.17
Exec Jul 15 2025
Filed Jul 17 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. $229K
2,750 sh × $83.13
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET